Summary:
- The article discusses a newly discovered toxin called TMAO (trimethylamine N-oxide) that can damage and destroy liver cells.
- Researchers have found a potential breakthrough in the form of a small molecule called FXR agonist, which can protect liver cells from the harmful effects of TMAO.
- The findings suggest that targeting the FXR pathway could be a promising therapeutic approach for liver diseases caused by TMAO toxicity.